This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Nociceptin receptor.
Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling through G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases.
Human | |
---|---|
Gene Name: | OPRL1 |
Uniprot: | P41146 |
Entrez: | 4987 |
Belongs to: |
---|
G-protein coupled receptor 1 family |
Kappa-type 3 opioid receptor; KOR-3; KOR-3MGC34578; N/OFQ Receptor; Nociceptin Receptor; NOCIR; NOP Receptor; OOR; OORORL1kappa3-related opioid receptor; opiate receptor-like 1; OPRL1; ORL1; Orphanin FQ Receptor
Mass (kDA):
40.693 kDA
Human | |
---|---|
Location: | 20q13.33 |
Sequence: | 20; NC_000020.11 (64080082..64100643) |
Detected in blood leukocytes.
Cell membrane; Multi-pass membrane protein. Cytoplasmic vesicle. Ligand binding leads to receptor internalization into cytoplasmic vesicles, decreasing the amount of available receptor at the cell surface. Internalization requires phosphorylation at Ser-363. Can recycle to the cell membrane.
PMID: 8137918 by Mollereau C., et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.
PMID: 11238602 by Serhan C.N., et al. Nociceptin stimulates neutrophil chemotaxis and recruitment: Inhibition by aspirin-triggered-15-Epi-lipoxin A4.